【中美创新时报2024 年9 月8 日波士顿讯】（记者温友平编译）据波士顿房地产时报报道， 马萨诸塞州波士顿——Related Beal 宣布已完成创新广场三期 (ISQ3) 融资，这是一个位于波士顿雷蒙德·L·弗林海洋公园 (RLFMP) 的 345,000 平方英尺的生命科学开发项目。
这一重要里程碑标志着 ISQ3 的最新阶段，以及 Related Beal 在东海港生命科学业务的持续扩张。该建筑将由 Vertex Pharmaceuticals (Vertex) 全面占用，该公司是海港第一家大型生物技术公司，也是该市全球生命科学中心的催化剂。
ISQ3 提供尖端研究设施，通过教育和就业机会为社区带来重大利益，优先考虑多样性、公平性和包容性，并成为可持续性和弹性的典范。 4 月，波士顿规划和发展局批准了最终开发商指定，将长期租约交给所有权集团，其中包括 Related Beal、三井不动产美国公司、Vertex、波士顿房地产包容基金 (BREIF) 和 Kavanagh 咨询集团。
“Related Beal 很高兴进入 ISQ3 开发的建设阶段，并与一支由合作伙伴、贷方和世界上最具影响力的生物技术领导者之一波士顿自己的 Vertex Pharmaceuticals 组成的优秀团队合作。我们很高兴能够推进这样一个独特的项目，我们很高兴很快就能动工，”Related Beal 执行副总裁 Stephen Faber 表示。“我们感谢我们的民选官员、波士顿的规划和经济发展团队、马萨诸塞州环境保护部以及 Raymond L. Flynn 海洋公园的尊贵邻居，感谢他们的支持，使这个项目成为负责任、可持续的经济发展的典范，这将极大地造福社区。”
ISQ3 是 Vertex 在与 Related Beal 共同开发的 RLFMP 中占用的第二座研究大楼。2022 年 2 月，Vertex 搬进了由 Related Beal 建造的 Jeffrey Leiden 细胞和基因治疗中心，并于当年晚些时候与 Related Beal 签署了 ISQ3 的租约，当时该地块正在被授予所有权。ISQ3 的新设施将被命名为 Jeffrey Leiden 细胞和基因治疗中心 II (Leiden II)，与 Leiden I 一起被称为 Leiden 校区。
为体现开发团队对可持续发展的承诺，ISQ3 还将成为波士顿第一座 LEED 白金级和零净碳生命科学建筑。该设施将采用高性能围护结构设计、使用热泵技术的机械、电气和管道电气化、通过屋顶光伏最大限度地产生现场可再生能源以及通过整个建筑生命周期评估减少碳排放等特点。
“该项目是欢迎女性和少数族裔投资者帮助缩小波士顿贫富差距的绝佳机会。此外，扩大对生物技术的了解和兴趣，让更多人参与其中，增强波士顿经济的实力，”BREIF 合伙人 Richard Taylor 表示。
BREIF 旨在为 BIPOC 提供前所未有的机会，让他们投资成熟市场的变革性项目，而他们过去一直被排除在外。对于 ISQ3，BREIF 与少数族裔女性拥有的企业 Basis Investment Group 合作，该企业通过其股权平台 BIG Equity 成为该项目的资本合作伙伴。桑坦德银行、Ullico、LBBW 和华盛顿资本正在提供建设融资。房地产公司 Newmark 协助 Related Beal 为该项目获得融资。
建立多元化团队的承诺在整个项目中得到了体现，超过 50% 的项目团队由少数族裔或女性拥有的企业组成。SGA 和 DREAM Collaborative 之间的合作伙伴关系正在领导该项目的建筑设计。 Related Beal Construction 和 Janey Construction Management 以及 Consigli 正在合作进行建筑施工。此外，InOrder Business 将担任建筑多样性顾问，以提高在项目施工期间将雇用的众多分包商的 DE&I 参与度。
该项目的重大公共利益包括对波士顿渔业基金会的支持，该基金会是波士顿南海滨的重要经济合作伙伴和邻居，以及 STEM 教育、生命科学技术工作培训和波士顿居民的就业机会。与格洛斯特海洋基因组研究所 (GMGI) 建立的战略合作伙伴关系将扩大 GMGI 在波士顿当地学校的初中和高中 STEM 教育计划，并使 GMGI 能够运营一个定制实验室，培训经过认证的生物制造技术人员进入不断增长的生命科学劳动力队伍。其他公共利益将支持重要的当地组织，如 No Books No Ball 篮球计划和辅导服务 PieRSquared。
ISQ3 位于海港北大街 331-339 号，将包括七层最先进的生命科学空间，以及各种现场设施，包括咖啡馆、健身中心、屋顶平台、会议和活动空间以及户外公共座位，以增强行人体验。
ISQ3 的建设正在进行中，预计将于 2026 年完工。该项目将为该市创造多达 700 个建筑岗位和约 500 个永久性就业岗位。
题图：创新广场三期。
附原英文报道
Related Beal Closes Financing on Innovation Square Phase III, a 345,000-SF Life Sciences Development
By Boston Real Estate Times -May 2, 2024
BOSTON, MA – Related Beal announced that it has closed financing on Innovation Square Phase III (ISQ3), a 345,000-square-foot life science development in Boston’s Raymond L. Flynn Marine Park (RLFMP).
This major milestone signifies the latest phase of ISQ3, and the continued expansion of Related Beal’s life science presence in the Eastern Seaport. The building will be fully occupied by Vertex Pharmaceuticals (Vertex), the first major biotech company in the Seaport and catalyst to the city’s global life science hub.
Delivering cutting-edge research facilities, ISQ3 offers significant community benefits through education and employment opportunities, prioritizes diversity, equity, and inclusion, and serves as a model for sustainability and resiliency. In April, the Boston Planning and Development Agency approved the final developer designation of the long-term lease to the ownership group, which includes Related Beal, Mitsui Fudosan America, Vertex, Boston Real Estate Inclusion Fund (BREIF), and Kavanagh Advisory Group.
“Related Beal is thrilled to enter the construction phase of the development of ISQ3 and work with an incredible team of partners, lenders, and one of the world’s most influential biotech leaders, Boston’s own Vertex Pharmaceuticals. We are thankful to move forward with such a unique project, and we are excited to soon put shovels in the ground,” said Stephen Faber, Executive Vice President of Related Beal. “We are grateful to our elected officials, Boston’s planning and economic development teams, the Massachusetts Department of Environmental Protection, and our valued neighbors in the Raymond L. Flynn Marine Park for their support in making this project a model for responsible, sustainable economic development that will greatly benefit the community.”
ISQ3 is Vertex’s second research building occupied in the RLFMP developed with Related Beal. In February of 2022, Vertex moved into the Jeffrey Leiden Center for Cell and Genetic Therapies built by Related Beal, and later that year signed a lease with Related Beal for ISQ3 while the parcel was being entitled. The new facility at ISQ3 will be named the Jeffrey Leiden Center for Cell and Genetic Therapies II (Leiden II) and, together with Leiden I, will be known as the Leiden Campus.
Reflecting the development team’s commitment to sustainability, ISQ3 will also be the first LEED Platinum and zero-net-carbon life sciences building in Boston. The facility will incorporate features such as a high-performance envelope design, mechanical, electrical, and plumbing electrification using heat pump technologies, maximum on-site renewable energy generation through rooftop photovoltaics, and a reduction in embodied carbon through a whole building life cycle assessment.
“This project is a tremendous opportunity to welcome women and minority investors to help close the wealth gap in Boston. Moreover, expanding exposure and interest in biotechnology to a wider range of people reinforces the strength of the Boston economy,” said Richard Taylor, BREIF Partner.
BREIF aims to provide BIPOC with unprecedented access to invest in transformative projects in mature markets from which they have been historically excluded. For ISQ3, BREIF partnered with Basis Investment Group, a minority-women-owned business enterprise, that is a capital partner in the project through its equity platform, BIG Equity. Santander Bank, Ullico, LBBW, and Washington Capital are providing construction financing. The real estate firm Newmark assisted Related Beal in obtaining financing for the project.
The commitment to building a diverse team is exemplified across the project, with over 50% of the project team comprised of minority- or women-owned businesses. The partnership between SGA and DREAM Collaborative is leading the project’s architectural design. Related Beal Construction and Janey Construction Management, along with Consigli, are collaborating on the building construction. Additionally, InOrder Business will act as a construction diversity consultant to elevate DE&I participation among the many sub-contractors who will be hired during the construction of the project.
Substantial public benefits from the project include support for the Boston Fisheries Foundation, an important economic partner and neighbor on the South Boston waterfront, as well as STEM education, technical job training in the life sciences, and employment for Boston residents. A strategic partnership established with The Gloucester Marine Genomics Institute (GMGI) will expand GMGI’s middle and high school STEM education programs in local Boston schools and enable GMGI to operate a custom lab to train certified biomanufacturing technicians to enter the growing life science workforce. Additional public benefits will support important local organizations such as the No Books No Ball basketball program and the tutoring service PieRSquared.
Located at 331-339 Northern Avenue in the Seaport, ISQ3 will include seven floors of state-of-the-art life sciences space in addition to a variety of on-site amenities including a café, fitness center, roof deck, conference and event space, and outdoor public seating for an enhanced pedestrian experience.
Construction on ISQ3 is underway and will be completed in 2026. The project will generate as many as 700 construction jobs and approximately 500 permanent jobs for the city.
